Goldiș, A.; Dragomir, R.; Mercioni, M.A.; Goldiș, C.; Sirca, D.; Enatescu, I.; Belei, O.
Introducing a Novel Personalized Microbiome-Based Treatment for Inflammatory Bowel Disease: Results from NostraBiome’s Internal Validation Study. Biomedicines 2025, 13, 795.
https://doi.org/10.3390/biomedicines13040795
AMA Style
Goldiș A, Dragomir R, Mercioni MA, Goldiș C, Sirca D, Enatescu I, Belei O.
Introducing a Novel Personalized Microbiome-Based Treatment for Inflammatory Bowel Disease: Results from NostraBiome’s Internal Validation Study. Biomedicines. 2025; 13(4):795.
https://doi.org/10.3390/biomedicines13040795
Chicago/Turabian Style
Goldiș, Adrian, Radu Dragomir, Marina Adriana Mercioni, Christian Goldiș, Diana Sirca, Ileana Enatescu, and Oana Belei.
2025. "Introducing a Novel Personalized Microbiome-Based Treatment for Inflammatory Bowel Disease: Results from NostraBiome’s Internal Validation Study" Biomedicines 13, no. 4: 795.
https://doi.org/10.3390/biomedicines13040795
APA Style
Goldiș, A., Dragomir, R., Mercioni, M. A., Goldiș, C., Sirca, D., Enatescu, I., & Belei, O.
(2025). Introducing a Novel Personalized Microbiome-Based Treatment for Inflammatory Bowel Disease: Results from NostraBiome’s Internal Validation Study. Biomedicines, 13(4), 795.
https://doi.org/10.3390/biomedicines13040795
